Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2026, Vol. 19 ›› Issue (02): 309-314. doi: 10.3877/cma.j.issn.1674-6902.2026.02.019

• Original Article • Previous Articles    

Study on the development trajectory and influencing factors of frailty in 429 elderly patients with chronic obstructive pulmonary disease

Ling Zheng1,2, Haiyan Yang1, Yan Cheng3, Binxue Xia2, Honghui Liu2, Hong Hu1, Maowen Yan1, Tianlu Wang1, Yuting Yang2, Hong Xiong1,()   

  1. 1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
    2College of Nursing, Southwest Medical University, Luzhou 646000, China
    3Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
  • Received:2025-12-17 Online:2026-04-25 Published:2026-05-12
  • Contact: Hong Xiong

Abstract:

Objective

To investigate the development trajectory and influencing factors of frailty in elderly patients with chronic obstructive pulmonary disease (COPD).

Methods

A total of 429 elderly COPD patients admitted to our hospital from January 2024 to September 2025 were selected as the study subjects. The frailty screening scale (FSS) was used to assess frailty at admission (T0), 1 month (T1), 3 months (T2), and 6 months (T3) of follow-up. Latent class growth modeling (LCGM) was applied to identify frailty development trajectories, resulting in three groups: a stable group (C1, 205 cases), an increasing group (C2, 70 cases), and a decreasing group (C3, 154 cases). Univariate analysis and multivariate logistic regression were used to analyze the influencing factors of different trajectories.

Results

At T0, 327 patients (76.22%) were frail, and at T3, 346 patients (80.65%) were frail. The correlation coefficients for frailty scores across T0, T1, T2, and T3 ranged from 0.553 to 0.685 (P<0.01). In the C1 group, the frailty score showed little change over the four time points, with an intercept of 2.68 and an average slope of 0.077. In the C2 group, the frailty score gradually increased over time, with an intercept of 0.97 and an average slope of 0.262. In the C3 group, the frailty score gradually decreased, with an intercept of 4.36 and an average slope of -0.257. Univariate analysis showed statistically significant differences in age, BMI, ethnicity, education level, disease duration, number of medication types, living alone, and grip strength among the different trajectory groups (P<0.05). Multivariate logistic regression showed that compared with the C1 group, BMI >24 (OR=6.957, 95%CI: 1.434~33.760, P=0.016), disease duration of 3~6 years (OR=0.335, 95%CI: 0.154~0.728, P=0.006), fear of progression (OR = 1.066, 95% CI: 1.014~1.121, P=0.012), and cognitive impairment (OR=1.068, 95% CI: 1.003~1.137, P=0.039) were factors associated with being in the C2 group. Compared with the C1 group, age ≥ 80 years (OR=2.277, 95%CI: 1.164~4.455, P=0.016), living alone (OR=6.031, 95%CI: 1.981~18.357, P=0.002), and grip strength (OR=1.051, 95%CI: 1.015~1.089, P=0.006) were factors associated with being in the C3 group. After 6 months of follow-up, 414 patients (96.50%) survived and 15 (3.50%) died, with a mortality rate of 8.57% in the C2 group, which was higher than that in the C1 group (2.44%) and the C3 group (2.60%).

Conclusion

The development of frailty in elderly COPD patients follows three distinct trajectories: stable, increasing, and decreasing. BMI, disease duration, fear of progression, cognitive impairment, living alone, grip strength, and age are influencing factors for different frailty trajectories. Dynamic monitoring of frailty trajectories may help identify high-risk individuals early and facilitate personalized interventions.

Key words: Chronic obstructive pulmonary disease, Frailty trajectory, Latent class, Influencing factors

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd